Cornell University researchers have created a new version of a microbe to compete economically with E. coli—a bacteria commonly used as a research tool due to its ability to synthesize proteins—to conduct low-cost and scalable synthetic biological experiments.
As an inexpensive multiplier—much like having a photocopier in a test tube—the bacteria Vibrio natriegens could help labs test protein variants for creation of pharmaceuticals, synthetic fuels and sustainable compounds that battle weeds or pests. The microbe can work effectively without costly incubators, shakers or deep freezers and can be engineered within hours.
The research was published Feb. 13 in PNAS Nexus.
“It’s really easy to produce,” said lead author David Specht, a postdoctoral researcher in the laboratory of Buz Barstow, assistant professor of biological and environmental engineering.
To study proteins for creating medical cures or fashioning fuels, researchers use a plasmid (a small piece of DNA) that acts as the instruction manual to make the molecular machine—a protein—of interest. Currently, when researchers place a plasmid into E. coli, they can create many copies to test several variants.
E. coli cells help molecular biologists multiply and manipulate plasmids for protein engineering, but the process is expensive since they often purchase the bacteria from manufacturers, must keep it cold and maintain rooms of expensive equipment to sustain it. A modified E. coli, used for this purpose, is also very fragile.”As scientists, we don’t often know precisely what those regulatory or molecular sequences should be to achieve our goals,” said Barstow. “So, we must test a lot of variants, and Vibrio natriegens allows researchers to scale up that process of testing.”
The microbe V. natriegens is not complicated, Specht said. “It’s so simple to make that someone with limited resources—like high school labs, home inventors or startup biological businesses—can do it,” he said.
Researcher Timothy Sheppard compared the simplicity of V. natriegens in conducting synthetic and molecular experiments to using a simple writing instrument hundreds of years old. “We’ve found nature’s pencil for cloning and conducting synthetic biology,” he said.
The process is inexpensive with V. natriegens, as it requires no capital equipment purchases and it can work at room temperature. The cells produced from V. natriegens grow quickly: According to the paper, a transformation started at 9 a.m. yields visible colonies by 5 p.m., each filled with masses of proteins.
“The microbe is a radically simple solution to a hard problem,” Barstow said.
More information: Efficient Natural Plasmid Transformation of Vibrio natriegens Enables Zero-capital Molecular Biology, PNAS Nexus (2024). DOI: 10.1093/pnasnexus/pgad444
Provided by Cornell University
News
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s agitation medications. A study conducted by researchers from Johns Hopkins University School of Medicine and Tufts University School of Medicine found that a pill form [...]
The Future of Rare Disease Treatment with Precision Medicine
Understanding rare diseases Rare diseases affect less than 5 people out of 10,000. However, this still amounts to about 7% of the world’s population, with over 10,000 such conditions. Almost all are genetic in [...]
Doctors issue warning for upcoming ‘tripledemic
The term ‘tripledemic’ has hit headlines this week as the NHS begins its Covid and fluvaccine roll-out for vulnerable adults. As the cold weather sets in, many of us have experienced a decline in health, and this may [...]
The FDA approved a gel that can stop bleeding from wounds in seconds
Aug 15 (Reuters) - The U.S. Food and Drug Administration has cleared Cresilon's gel to quickly control bleeding, the privately held company said on Thursday, potentially giving emergency medical technicians and combat medics a [...]
High levels of microplastics found in prostate tumors, possibly linked to take-out food
The presence of microplastics in prostate tumors points to potential health risks, and researchers are calling for urgent studies to explore how take-out food may be driving this exposure. In a recent study published [...]
AI outperforms radiologists in brain tumor diagnosis
As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field of radiology, where a correct diagnosis is crucial to ensure [...]
Breakthrough Study Reveals Molecular Clues to Dementia Origins
Work could lead to the discovery of new therapeutic targets. For the first time, researchers have identified “molecular markers” linked to degeneration—detectable changes in cells and their gene-regulating networks—that are common across several types [...]
Better than blood tests? Nanoparticle potential found for assessing kidneys
In a study published July 29 in Advanced Materials, University of Texas at Dallas researchers found that X-rays of the kidneys using gold nanoparticles as a contrast agent might be more accurate in detecting kidney [...]
Greener nanomaterials could transform how our everyday stuff is made
Tiny nanoparticles are at the forefront of materials science—with special properties that make them great at absorbing light in solar panels, cleaning wastewater, and delivering drugs precisely. Some nanoparticles take the form of sheets or fibers. But nanomaterials all [...]
AI could predict breast cancer risk via ‘zombie cells’
Women worldwide could see better treatment with new AI technology, which enables better detection of damaged cells and more precisely predicts the risk of getting breast cancer, shows new research from the [...]
Through the eyes of a cat – biomimicry of feline eyes may revolutionize robotic vision
In a recent study published in the journal Science Advances, researchers leveraged crucial aspects of feline eyes, particularly their tapetum lucidum and vertically elongated pupils (VP), to develop a monocular artificial vision system capable of [...]
New Alzheimer’s Therapy Shows Remarkable Results in Animal Trials
A study from TUM demonstrates a promising therapeutic approach. Researchers at the Technical University of Munich (TUM) have made promising advances in preventing Alzheimer’s by developing a new therapeutic strategy. Their approach focuses on targeting the amyloid beta [...]
Rewriting Cancer’s Blueprint: New Study Challenges Old Theories
A new study argues for a revised clonal evolution model of cancer, incorporating genetic and non-genetic factors to improve understanding and treatment. Like all living organisms, cancer cells are driven by the fundamental need [...]
Microplastics Everywhere: Experts Demand Worldwide Treaty Before It’s Too Late
A new report calls for global action on plastic pollution, urging reductions in plastic production and microplastic emissions. Researchers stress the importance of addressing plastic pollution through both scientific and social science perspectives. A [...]
Blood tests could soon predict your risk of Alzheimer’s
Scientists are closing in on biomarkers that reflect the progression of Alzheimer’s disease and could improve treatments. Like many Alzheimer’s researchers, neurologist Randall Bateman is not prone to effusiveness, having endured disappointments in his [...]